About Us
Based in Frederick, Maryland, Nanocrine is pioneering the commercial availability of nanoplasmonic biosensors for everyday use in leading cell biology laboratories. We design our biosensors as single use biochips that work with standard live cell microscopes and require no new instrumentation – simply open the packages, gather data, and achieve breakthrough results at affordable prices.
Nanocrine plasmonic biosensors are being developed to image the protein secretions of live cells in real time. Our goal is to empower researchers with the capacity to obtain advanced understanding of their cells' behaviors, enhancing the precision and reproducibility of their live cell imaging experiments.
-
Our cell surface chemistry expertise improves live cell phenotyping and reproducibility.
-
Our Contact Guidance surfaces provide atomically smooth features with precise channel depths that improve the precision of cell behavior studies.
-
Our nanoplasmonic biosensors are being applied to elucidate cell messaging relevant to stem cell research, neurodegenerative and cardiovascular disease, and oncology.
The Plasmonic Imaging Company
Unlocking Cell-to-Cell Messaging
Interested parties, please contact Investor Relations to request further information, including access to the Data Room or to set up a meeting.
Management
Patrick Calhoun, Ph.D.
President & Chief Science Officer
Cell Biologist/Virologist with focus in cellular communication, intracellular signaling
Patrick received his PhD from Virginia Tech followed by postdoctoral training at Johns Hopkins School of Medicine. His scientific interests include intercellular communication, intracellular signaling pathways, and viral pathogenesis. He joined Nanocrine to lead cell biology advancements and product development, including a platform for label-free phenotype-based assays for determination of viral infection.
Steve Turner
Co-Founder, Chairman
Life Sciences Business Development
Steve has a forty-year career serving as founder and executive of life science companies, including the BRL Division of Life Technologies, Oncor, OncorMed, and Quorum Sciences. He focuses on commercializing new life science technology platforms and served as Director of Marketing for the Microbiology Division of Becton, Dickinson & Co. He is a graduate of Stanford University.
Marc Raphael, Ph.D.
Advisor, Technology Inventor
Biophysics Laboratory Director,
U.S. Naval Research Laboratory
Marc received his PhD in physics from Catholic University and leads an interdisciplinary team of physicists, material scientists, and bioengineers at the United States Naval Research Laboratory in Washington, D.C.
He is the inventor of the technology used in the Nanocrine Plasmonic Chip.
Custom Services
-
Custom in vitro surfaces functionalized with the peptide or protein of your choice.
-
Chemically modified surfaces for sensor applications.
-
Dry-etched quartz surface topography.
Custom Cell Biology Services
-
Transfection/transduction
-
Cytotoxicity assays
-
Cell lysate preparation
Aliquot Services
-
Precisely weighed solid reagents to accelerate your workflow
-
Guaranteed weight accuracy within 5%
-
Weighing range of 7 mg to 220 g